C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
09/1992
09/02/1992	EP0501322A1 3-Piperidinylmethylcarboxylate substituted indoles
08/1992
08/28/1992	WO1992015580A1 NEUROLEPTIC PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
08/28/1992	WO1992015561A2 Process for preparing trans-piperidine-2,5-dicarboxylates
08/26/1992	CA2104000A1 4-[(2-benzothiazolyl)methylamino] -.alpha.-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol
08/21/1992	WO1992014716A1 2,4-diaminoquinazolines derivatives for enhancing antitumor activity
08/21/1992	CA2101542A1 2,4-diaminoquinazolines derivatives for enhancing antitumor activity
08/19/1992	EP0499501A2 New macrocyclic nitrogen ligands, method for their preparation, metal complexes, diagnostic and therapeutic compositions
08/19/1992	EP0499231A1 9-Aminotetrahydroacridines and related compounds, a process for their preparation and their use as medicaments
08/19/1992	EP0233284B1 Pharmacological compounds
08/18/1992	US5140023 Azatetracycle compounds
08/17/1992	CA2104108A1 Substituted pyridinones and pyrimidinones as angiotensin ii antagonists
08/14/1992	CA2061084A1 9-aminotetrahydroacridines and related compounds, a process for their preparation and their use as medicaments
08/13/1992	WO1992013856A1 5-heteroyl indole derivatives
08/13/1992	WO1992013847A1 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
08/13/1992	CA2101521A1 5-heteroyl indole derivatives
08/13/1992	CA2100160A1 3-substituted 1,2,3,4-oxatriazole-5-imine compounds, a process for the preparation thereof and a pharmaceutical preparation containing said compounds
08/12/1992	EP0497926A1 Multi-site metal chelating agents
08/12/1992	EP0497910A1 Camptothecin analogs as potent inhibitors of human colorectal cancer
08/12/1992	CN1063490A Sulfonylureas compounds
08/11/1992	US5138060 Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
08/11/1992	US5137913 Diaryl ether cyclic ethers
08/11/1992	CA1306255C Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives
08/10/1992	CA2060937A1 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation
08/08/1992	WO1992013848A1 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives
08/08/1992	CA2101539A1 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives
08/06/1992	WO1992001675A3 Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene b4 antagonist activity, their preparation and use in pharmaceutical compositions
08/05/1992	CN1063281A 2-aryl-5-trifluoromethyl-2-pyrroline compounds and process for manufacture of insecticidal, 2-aryl-1-(alkoxymethyl)-4-halo-5-(trifluoromethyl)
08/04/1992	US5136060 Method for preparation of taxol using an oxazinone
07/1992
07/30/1992	WO1992012969A1 Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion
07/30/1992	CA2099117A1 Salts of a 4-amino-3-acyl quinoline derivative and their use as inhibitors of gastric acid secretion
07/29/1992	EP0496701A1 Sulfonylureas as herbizides
07/25/1992	WO1992012978A1 Novel nitrogenous macrocyclic ligands, their preparation method, polymetallic complexes, and a diagnostic and therapeutical composition
07/25/1992	CA2078983A1 Nitrogen macrocyclic ligands, preparation method, complex polymetallic diagnostic composition and therapeutical
07/23/1992	WO1992012135A1 (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile
07/22/1992	CN1062906A Process for preparing 8-chloroquinolone derivatives
07/15/1992	CN1062731A Process for preparation of water soluble camptothecin analogs and intermediates thereof, compounds prepared by said process, and methods of use thereof
07/15/1992	CN1062730A N-acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for preparing same
07/08/1992	EP0202282B1 New use of 1,4-dihydropyridine derivatives
07/08/1992	CN1062529A Indole derivatives
07/04/1992	WO1992012152A1 Process and intermediates for preparing azabicyclo[2.2.2]octan-3-imines
07/01/1992	EP0492485A1 N-Acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for preparing same
07/01/1992	EP0492171A1 2-Aryl-5-trifluoromethyl)-2-pyrroline compounds and process for the manufacture of insecticidal, 2-aryl-1-(alkoxymethyl)-4-halo-5-(trofluoromethyl) pyrroles
07/01/1992	EP0491751A1 Antiviral tetrahydroimidazo 1,4]benzodiazepines
06/1992
06/30/1992	US5126445 Process for the preparation of cefodizime sodium
06/30/1992	US5126338 Fungicides which are n-pyridyl-cyclopropane carboxamides or derivatives thereof
06/25/1992	WO1992010491A1 Antiallergic compounds
06/24/1992	CN1062139A Process for preparation of phenoxyprimidine compounds
06/23/1992	US5124329 For plants
06/17/1992	CN1061968A Process for preparing ranitidine
06/16/1992	CA1303611C Chromogenic acridinone enzyme substrates
06/14/1992	CA2044859A1 Formation of hydroxyaromatic ketoacetal from an hydroxyaromatic methylketone and production of 5-(4'-hydroxyphenyl)hydantoin and d-p-hydroxyphenylglycine from 4 hydroxyacetophenone
06/10/1992	EP0131006B1 Esters of 3-(3-substituted-amino-2-hydroxypropoxy)-4-substituted-1,2,5-thiadiazole derivatives
06/09/1992	US5120855 Formation of hydroxyaromatic ketoacetal from a hydroxyaromatic methylketone and production of 5-(4'-hydroxyphenyl)hydantoin and Dp-hydroxyphenylglycine from 4-hydroxyacetophenone
06/09/1992	US5120841 Antibiotics for easy absorption
06/03/1992	CN1061602A Process for preparing 7-acyl-3-(substituted carbambytoxy) cephem compound
06/03/1992	CN1016871B Process for the preparation of tricyclische pyridinderivate and their use
05/1992
05/29/1992	WO1992008721A1 Novel cephalosporin compounds and processes for preparation thereof
05/29/1992	WO1992008692A1 Oxysulfonyl urea acat inhibitors
05/27/1992	EP0486948A2 Retroviral protease inhibiting compounds
05/27/1992	EP0486734A1 1-Aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disorders
05/27/1992	CN1061414A Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
05/27/1992	CN1061411A Quinazolines derivatives for enhancing antitumor
05/27/1992	CN1061407A Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
05/20/1992	CN1016692B Method for preparation of trycyclic pyridazopyridone derivatives
05/19/1992	US5114934 Tricyclic pyridone derivatives
05/17/1992	WO1992008703A1 Process for the preparation of pyrimidine compounds
05/13/1992	EP0484966A2 7-Acyl-3-(substituted carbamoyloxy) cephem compounds, use thereof and process for their preparation
05/13/1992	EP0484881A2 Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
05/13/1992	CN1016607B Method for preparing crystalline cefadroxil monoltyrate
05/12/1992	US5112822 Gastrointestinal disorders and glaucoma treatment
05/10/1992	CA2072883A1 Cephalosporin compounds and processes for preparation thereof
05/10/1992	CA2055189A1 Process for preparing 1-{2-¬ (5-dimethyllaminomethyl-2-furyl) -methylthio)-ethyl)-amino-1-methylamino-2-nitroethylene
05/07/1992	WO1992007844A1 Quinazolines derivatives for enhancing antitumor activity
05/07/1992	CA2095213A1 Quinazoline derivatives for enhancing antitumor activity
05/06/1992	EP0483881A1 3-Amidoindolyl derivatives
05/05/1992	CA1300161C Carboxamido dihydrobenzofuran and chroman derivatives, their preparation process and their use as neuroleptics
04/1992
04/30/1992	WO1992006973A1 Indole derivatives
04/29/1992	EP0483063A1 Ergoline derivatives
04/29/1992	CN1016420B Dihydrobenzofuran-and chromancarboxamide derivatives, processes for the preparation thereof and use thereof as neuroleptics
04/28/1992	US5109132 Process for the preparation of 3-exomethylene cepham derivatives
04/28/1992	US5108997 Cephem compounds
04/22/1992	EP0481254A2 2-(4-Piperidinyl)-1H-pyrido[4,3-b]indol-1 ones and related compounds, intermediates and a process for their preparation
04/22/1992	CN1060469A Process for preparing cephalosporins derivants
04/21/1992	US5106981 Skin disorders
04/21/1992	CA2053712A1 Ergoline derivatives
04/21/1992	CA1299186C 4(5)-substituted imadazole derivatives
04/21/1992	CA1299178C Heterocyclic oxophtalazinyl acetic acids
04/16/1992	WO1992005785A1 Water soluble camptothecin analogues, processes and methods
04/15/1992	EP0480717A1 Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
04/15/1992	CN1060285A Fused ring analogs of nitrogen containing nonaromatic heterocycles
04/07/1992	US5102894 Antihyporic, antiischemic, antiepileptic agents
04/07/1992	US5102889 2-(4-piperidinyl)-1H-pyrido[4,3-b]indol-1-ones and related compounds
03/1992
03/31/1992	US5100887 Bactericides
03/31/1992	CA1298288C Cephalosporin salts and injectable compositions
03/29/1992	WO1992006079A1 Fused ring analogs of nitrogen containing nonaromatic heterocycles
03/29/1992	CA2089736A1 Fused ring analogs of nitrogen containing nonaromatic heterocycles
03/19/1992	WO1991019704A3 Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
03/17/1992	US5097047 Fungicidal and plant growth-regulating azolylmethyl-cyclopropyl derivatives
03/17/1992	CA1297473C Crystallized cephem-acid addition salts, and a process for the preparation thereof
03/10/1992	CA1297121C Process for the preparation of perhalohydrocarbon hypochlorites

1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 105